Back
Seres Therapeutics Stock Price Chart
Sponsored
MCRB
Sponsored
Wall St Issues Rare "SELL" alert
MarketBeat is making the full list completely FREE for a limited time.
Sell
35
MCRB
Seres Therapeutics
Last Price:
0.92
Seasonality Move:
-14.51%
7 Day Trial
ALL ACCESS PASS
$
7
Invest in the Next Big AI Disruptor Today
Learn More- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MCRB is experiencing slight selling pressure.
Seres Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.02 | Sell |
20-day SMA: | 0.98 | Sell |
50-day SMA: | 1.02 | Sell |
200-day SMA: | 0.99 | Sell |
8-day EMA: | 0.98 | Sell |
20-day EMA: | 0.98 | Sell |
50-day EMA: | 0.98 | Sell |
200-day EMA: | 1.3 | Sell |
Seres Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 45.95 | Sell |
Chaikin Money Flow: | -775790 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.84 - 1.06) | Sell |
Bollinger Bands (100): | (0.78 - 1.14) | Sell |
Seres Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Seres Therapeutics Stock
Is Seres Therapeutics Stock a Buy?
- Seres Therapeutics share price is 0.92 while MCRB 8-day simple moving average is 1.02, which is a Sell signal.
- The stock price of MCRB is 0.92 while Seres Therapeutics 20-day SMA is 0.98, which makes it a Sell.
- Seres Therapeutics 50-day simple moving average is 1.02 while MCRB share price is 0.92, making it a Sell technically.
- MCRB stock price is 0.92 and Seres Therapeutics 200-day simple moving average is 0.99, creating a Sell signal.
MCRB Technical Analysis vs Fundamental Analysis
Sell
35
Seres Therapeutics (MCRB)
is a Sell
Is Seres Therapeutics a Buy or a Sell?
-
Seres Therapeutics stock is rated a Sell
The current Seres Therapeutics [MCRB] share price is $0.92. The Score for MCRB is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Seres Therapeutics Stock Info
Market Cap:
139.43M
Price in USD:
0.92
Share Volume:
10.81M
Seres Therapeutics 52-Week Range
52-Week High:
2.46
52-Week Low:
0.54
Sell
35
Seres Therapeutics (MCRB)
is a Sell
Seres Therapeutics Share Price Forecast
-
What is the Seres Therapeutics stock price today?
The Seres Therapeutics stock price is 0.92 USD today. -
Will MCRB stock go up or go down?
Seres Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Seres Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Seres Therapeutics is overvalued.
Is Seres Therapeutics Stock a Buy?
- Seres Therapeutics share price is 0.92 while MCRB 8-day exponential moving average is 0.98, which is a Sell signal.
- The stock price of MCRB is 0.92 while Seres Therapeutics 20-day EMA is 0.98, which makes it a Sell.
- Seres Therapeutics 50-day exponential moving average is 0.98 while MCRB share price is 0.92, making it a Sell technically.
- MCRB stock price is 0.92 and Seres Therapeutics 200-day simple moving average is 1.30, creating a Sell signal.
Fundamental Analysis of Seres Therapeutics
Is Seres Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.49 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.27 per share, and an increase next year of $0.17 per share.
Technical Analysis of Seres Therapeutics
Should I short Seres Therapeutics stock?
- MCRB Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Seres Therapeutics is a Buy
- Seres Therapeutics Relative Strength Index (RSI) is 45.95, which suggest Seres Therapeutics is oversold
- The Bollinger Bands (25) for Seres Therapeutics is (0.84 - 1.06), which suggest Seres Therapeutics is a Sell
- The Bollinger Bands (100) for Seres Therapeutics is (0.78 - 1.14), which suggest Seres Therapeutics is a Sell
* Seres Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.